Clinical exclusivity for indigenous medicines can improve long-term affordability and access
Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clinical data exclusivity, competitors may obtain…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ENTOD Pharma
ENTOD’s PresVu eye drops gain DCGI approval
PresVu aims to reduce dependency on reading glasses for individuals affected by presbyopia
Entod Pharma launches Vitamin D3 eye drops
The formulation aims to benefit ocular health, providing targeted relief for individuals suffering from dry eyes
Top trends in pharma marketing in 2022 will continue to dominate the sector in 2023
As a part of Express Pharma’s January 2023 cover story, Nikkhil K Masurkar, CEO, Entod Pharma, shares his views below.
The…
Entod Pharma’s eye drop might replace reading glasses soon
Entod Pharma is in the final stages of developing the eye drop known as "PresVu"
Entod launches snake venom-based facial gel serum in India
The serum is already a well-known product in the European market
Entod Pharma gets DCGI nod to carry out phase-III trial of Atropine eye drops
Subject to a successful demonstration of safety and efficacy in clinical studies, Entod Pharma would be the first company to…
India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug…
Inefficient clinical research, low productivity, low learning and study curve, lack of facilities and trained investigators, etc.…